Modern Trials reduces time-to-market for new therapeutics
by filling clinical trials with representative samples
at 80% of in-house recruitment cost (coming 2025)
Increased Revenue
Decreased time-to-market for new therapeutics, translating to increased revenue and profitability
Cost Savings
Cost savings via recruitment services provided at ~80% of in-house variable costs
Headache Reduction
Removal of largest pain point in the clinical trial process
Value First
Examine detailed medical records of prescreened candidates before investing $ in approach or life screening
Reduced Risk & Associated Costs
Fewer adverse events, black box warnings and Phase IV trials via more representative sampling
